The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 11,853 | 675,000 | SH | SOLE | 675,000 | 0 | 0 | ||
ALIGOS THERAPEUTICS INC | COM | 01626L105 | 4,339 | 212,785 | SH | SOLE | 212,785 | 0 | 0 | ||
ALX ONCOLOGY HLDGS INC | COM | 00166B105 | 172,624 | 3,156,981 | SH | SOLE | 3,156,981 | 0 | 0 | ||
ANNEXON INC | COM | 03589W102 | 3,593 | 159,622 | SH | SOLE | 159,622 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 22,120 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 2,144 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
ASLAN PHARMACEUTICALS LTD | ADS | 04522R101 | 6,600 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
ATHIRA PHARMA INC | COM | 04746L104 | 14,447 | 1,410,812 | SH | SOLE | 1,410,812 | 0 | 0 | ||
BCTG ACQUISITION CORP | COM | 05492W103 | 2,276 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | 21,707 | 715,000 | SH | SOLE | 715,000 | 0 | 0 | ||
BIOMEA FUSION INC | COM | 09077A106 | 18,144 | 1,162,320 | SH | SOLE | 1,162,320 | 0 | 0 | ||
C4 THERAPEUTICS INC | COM STK | 12529R107 | 4,273 | 112,928 | SH | SOLE | 112,928 | 0 | 0 | ||
CATABASIS PHARMACEUTICALS IN | COM NEW | 14875P206 | 6,731 | 3,190,000 | SH | SOLE | 3,190,000 | 0 | 0 | ||
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 20,867 | 939,545 | SH | SOLE | 939,545 | 0 | 0 | ||
CENTURY THERAPEUTICS INC | COM | 15673T100 | 29,020 | 989,095 | SH | SOLE | 989,095 | 0 | 0 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 11,520 | 1,420,500 | SH | SOLE | 1,420,500 | 0 | 0 | ||
COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | 32,428 | 850,000 | SH | SOLE | 850,000 | 0 | 0 | ||
CULLINAN ONCOLOGY INC | COM | 230031106 | 7,428 | 288,458 | SH | SOLE | 288,458 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 27,706 | 1,400,000 | SH | SOLE | 1,400,000 | 0 | 0 | ||
DAY ONE BIOPHARMACEUTICALS I | COM | 23954D109 | 844 | 37,069 | SH | SOLE | 37,069 | 0 | 0 | ||
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 40,271 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | ||
DESIGN THERAPEUTICS INC | COM | 25056L103 | 54,349 | 2,732,501 | SH | SOLE | 2,732,501 | 0 | 0 | ||
DYNE THERAPEUTICS INC | COM | 26818M108 | 43,224 | 2,054,392 | SH | SOLE | 2,054,392 | 0 | 0 | ||
EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 26,275 | 1,231,812 | SH | SOLE | 1,231,812 | 0 | 0 | ||
ELEDON PHARMACEUTICALS INC | COM | 28617K101 | 1,772 | 224,071 | SH | SOLE | 224,071 | 0 | 0 | ||
FORMA THERAPEUTICS HLDGS INC | SHS | 34633R104 | 30,241 | 1,215,000 | SH | SOLE | 1,215,000 | 0 | 0 | ||
FS DEVELOPMENT CORP II | COM CL A | 30318F100 | 1,233 | 123,543 | SH | SOLE | 123,543 | 0 | 0 | ||
GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | 15,740 | 724,333 | SH | SOLE | 724,333 | 0 | 0 | ||
GRAPHITE BIO INC | COM | 38870X104 | 32,905 | 1,070,762 | SH | SOLE | 1,070,762 | 0 | 0 | ||
HARPOON THERAPEUTICS INC | COM | 41358P106 | 11,096 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 1,020 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
HELIX ACQUISITION CORP | COM CL A | G4444C102 | 518 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
IKENA ONCOLOGY INC | COM | 45175G108 | 4,210 | 299,853 | SH | SOLE | 299,853 | 0 | 0 | ||
INSTIL BIO INC | COM | 45783C101 | 32,783 | 1,696,850 | SH | SOLE | 1,696,850 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 29,273 | 1,125,000 | SH | SOLE | 1,125,000 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 15,775 | 2,500,000 | SH | SOLE | 2,500,000 | 0 | 0 | ||
JANUX THERAPEUTICS INC | COM | 47103J105 | 13,651 | 547,122 | SH | SOLE | 547,122 | 0 | 0 | ||
KARUNA THERAPEUTICS INC | COM | 48576A100 | 37,047 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 12,489 | 2,300,000 | SH | SOLE | 2,300,000 | 0 | 0 | ||
KINIKSA PHARMACEUTICALS LTD | COM CL A | G5269C101 | 11,144 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
KINNATE BIOPHARMA INC | COM | 49705R105 | 30,953 | 1,329,602 | SH | SOLE | 1,329,602 | 0 | 0 | ||
LANDOS BIOPHARMA INC | COM | 515069102 | 10,385 | 899,106 | SH | SOLE | 899,106 | 0 | 0 | ||
MEREO BIOPHARMA GROUP PLC | ADS | 589492107 | 149 | 46,984 | SH | SOLE | 46,984 | 0 | 0 | ||
MONTE ROSA THERAPEUTICS INC | COM | 61225M102 | 6,810 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
NKARTA INC | COM | 65487U108 | 31,765 | 1,002,382 | SH | SOLE | 1,002,382 | 0 | 0 | ||
NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 173 | 66,666 | SH | SOLE | 66,666 | 0 | 0 | ||
OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 104,754 | 3,743,875 | SH | SOLE | 3,743,875 | 0 | 0 | ||
PASSAGE BIO INC | COM | 702712100 | 1,655 | 125,010 | SH | SOLE | 125,010 | 0 | 0 | ||
PMV PHARMACEUTICALS INC | COM | 69353Y103 | 7,056 | 206,564 | SH | SOLE | 206,564 | 0 | 0 | ||
PRELUDE THERAPEUTICS INC | COM | 74065P101 | 11,452 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
RAIN THERAPEUTICS INC | COM | 75082Q105 | 12,126 | 780,331 | SH | SOLE | 780,331 | 0 | 0 | ||
RAPT THERAPEUTICS INC | COM | 75382E109 | 8,583 | 270,000 | SH | SOLE | 270,000 | 0 | 0 | ||
RAPT THERAPEUTICS INC | COM | 75382E109 | 23,843 | 750,000 | SH | Call | SOLE | 750,000 | 0 | 0 | |
REPARE THERAPEUTICS INC | COM | 760273102 | 10,289 | 330,000 | SH | SOLE | 330,000 | 0 | 0 | ||
RESEARCH ALLIANCE CORP II | COM CL A | 760873109 | 1,014 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
TALARIS THERAPEUTICS INC | COM | 87410C104 | 7,461 | 507,923 | SH | SOLE | 507,923 | 0 | 0 | ||
TURNING POINT THERAPEUTICS I | COM | 90041T108 | 31,208 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
VERVE THERAPEUTICS INC | COM | 92539P101 | 45,685 | 758,265 | SH | SOLE | 758,265 | 0 | 0 |